Darshan Shastri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Darshan Shastri has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Charles Joseph Prestigiacomo
Department of Neurosurgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
2 shared publications Tareq Kass-Hout
Division of Endovascular Neurosurgery, Department of Neurological Surgery, Rutgers University, New Jersey Medical School, Newark, New Jersey, USA; Department of Surgery, Rochester Regional Health System, Rochester, New York, USA
2 shared publications- Yazan J. Alderazi
HCA Houston Healthcare Clear Lake
2 shared publications Chirag D. Gandhi
Division of Endovascular Neurosurgery, Department of Neurological Surgery, Rutgers University, New Jersey Medical School, Newark, New Jersey, USA
1 shared publication- Chirag D. Gandhi
Department of Neurosurgery and Neuroscience, Rutgers University School of Medicine, Newark, N.J, N.Y., USA
1 shared publication Chirag Gandhi
Department of Neurosurgery, Westchester Medical Center at NY Medical College, Valhalla, New York, USA
1 shared publication
Latest Publications
- 1 February 2019
- Published by Elsevier in World Neurosurgery
- Vol. 122, e961-e968
Hemorrhagic Complications of External Ventriculostomy in the Aspirin and P2Y12 Response Assay Era
- 1 February 2019
- Published by Elsevier in World Neurosurgery
- Vol. 122, e961-e968
Hemorrhagic Complications of External Ventriculostomy in the Aspirin and P2Y12 Response Assay Era
- 1 May 2017
- Published by Elsevier in World Neurosurgery
- Vol. 101, 254-258
Internal Maxillary Artery Preoperative Embolization Using n-Butyl Cyanoacrylate and Pushable Coils for Temporomandibular Joint Ankylosis Surgery
- 1 May 2017
- Published by Elsevier in World Neurosurgery
- Vol. 101, 254-258
Internal Maxillary Artery Preoperative Embolization Using n-Butyl Cyanoacrylate and Pushable Coils for Temporomandibular Joint Ankylosis Surgery
- Open Access
- 20 May 2014
- Published by Wiley in Stroke Research and Treatment
- Vol. 2014, 1-12
Flow Diverters for Intracranial Aneurysms
Flow diverters (pipeline embolization device, Silk flow diverter, and Surpass flow diverter) have been developed to treat intracranial aneurysms. These endovascular devices are placed within the parent artery rather than the aneurysm sac. They take advantage of altering hemodynamics at the aneurysm/parent vessel interface, resulting in gradual thrombosis of the aneurysm occurring over time. Subsequent inflammatory response, healing, and endothelial growth shrink the aneurysm and reconstruct the parent artery lumen while preserving perforators and side branches in most cases. Flow diverters have already allowed treatment of previously untreatable wide neck and giant aneurysms. There are risks with flow diverters including in-stent thrombosis, perianeurysmal edema, distant and delayed hemorrhages, and perforator occlusions. Comparative efficacy and safety against other therapies are being studied in ongoing trials. Antiplatelet therapy is mandatory with flow diverters, which has highlighted the need for better evidence for monitoring and tailoring antiplatelet therapy. In this paper we review the devices, their uses, associated complications, evidence base, and ongoing studies.
- 20 May 2014
- Published by Wiley in Stroke Research and Treatment
- Vol. 2014, 1-12
Open AccessFlow Diverters for Intracranial Aneurysms
Flow diverters (pipeline embolization device, Silk flow diverter, and Surpass flow diverter) have been developed to treat intracranial aneurysms. These endovascular devices are placed within the parent artery rather than the aneurysm sac. They take advantage of altering hemodynamics at the aneurysm/parent vessel interface, resulting in gradual thrombosis of the aneurysm occurring over time. Subsequent inflammatory response, healing, and endothelial growth shrink the aneurysm and reconstruct the parent artery lumen while preserving perforators and side branches in most cases. Flow diverters have already allowed treatment of previously untreatable wide neck and giant aneurysms. There are risks with flow diverters including in-stent thrombosis, perianeurysmal edema, distant and delayed hemorrhages, and perforator occlusions. Comparative efficacy and safety against other therapies are being studied in ongoing trials. Antiplatelet therapy is mandatory with flow diverters, which has highlighted the need for better evidence for monitoring and tailoring antiplatelet therapy. In this paper we review the devices, their uses, associated complications, evidence base, and ongoing studies.